ARCHIVES

Three Cancer Centers Test Targeted Therapy For Resistant Acute Myelogenous Leukemia

This article is from The Cancer Letter archive.

Vol. 25 No. 7 | July 26, 2002

Download PDF Visit The Full Archive

Related Articles

NIH Cool On OIG, But the Awardees Love it, DeVita Says

October 17, 1986

Galeterone Shows Potential In CRPC AR Variants, Study Says

November 28, 2014

Chemo Combinations Tested In Phase III For Lung Cancer

August 31, 2001

In Brief: Ames, Rowley, Win National Science Medals; New Building Planned for Pittsburgh Center

January 8, 1999

NCI, Canary Foundation Fund Biomarker Studies In Lung Cancer Of Never-Smokers

May 8, 2009

Facility Needs Panel Recommends $4.5-3 billion, Seven Year Program To Be Run By NIGMS Or DRR

March 4, 1988